top of page

Turhan et al.

Am J Gastroenterol
. 2009 Nov;104(11):2874-7.

Topical Ankaferd Blood Stopper Administration to Bleeding Gastrointestinal Carcinomas Decreases Tumor Vascularization

Uzun et al.

Epub 2014 Feb 1.

Effective Management of Hemoptysis Via
Endobronchial Application of Ankaferd Hemostat

Patıroglu et al.

Turk J Hematol 2018;35:75-93

Effectiveness of Ankaferd BloodStopper in
Prophylaxis and Treatment of Oral Mucositis in
Childhood Cancers Evaluated with Plasma Citrulline Levels

M Kurt, IK Onal, M Akdogan, et al

Can J Gastroenterol 2010;24(6):380-384.

Atay et al.

Int J Hematol Oncol 2015; 25: 166–171 [48]

Safety and Efficacy of Ankaferd Hemostat (ABS)
in the Chemotherapy-Induced Oral Mucositis

Eyi et al.

Clin Exp Obstet Gynecol 2013; 40: 141-143 [47]

Ankaferd blood stopper in episiotomy repair

Yasar et al

Afr J Tradit Complem 2011; 8: 444-446 [45]


Atalay et al.

Open Cardiovasc Med J 2015; 9: 18-25 [44]

Ankaferd Blood Stopper Decreases Postoperative Bleeding
and Number of Transfusions in Patients Treated with Clopidogrel

Istanbulluoglu et al.

J Endourol 2013; 27: 1126-1130 [42]

A New Hemostatic Agent (Ankaferd Blood Stopper) in Tubeless
Percutaneous Nephrolithotomy

Pamuk et al.

J Periodontal Res 2016; 51: 540-547 [41]

Ankaferd blood stopper enhances healing after
osseous grafting in patients with intrabony periodontal defects

Guler et al.

J Invest Surg 2011; 24: 205–210 [40]

The Efficacy of Ankaferd Blood Stopper for the
Managment of Bleeding Following Total Thyroidectomy

Teker et al

Int J Pediatr Otorhinolaryngol 2009; 73: 1742-1745 [39]

Prospective, controlled clinical trial of Ankaferd
Blood Stopper in children undergoing tonsillectomy

bottom of page